BridgeMD
New treatment option for Psoriatic Arthritis
Official title Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
ClinicalTrials.gov ID: NCT07486960
What this study is testing
What is Tulisokibart?
Tulisokibart is an investigational medicine, given as an injection under the skin, being studied as a potential treatment for psoriatic arthritis.
Also referred to as MK-7240, PRA023.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Researchers are looking for new ways to treat Psoriatic Arthritis (PsA). This study will help find out if a study medicine called tulisokibart (MK-7240) can treat symptoms of active PsA.
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- The main include but are not limited to the following:
- Has a clinical diagnosis of PsA and fulfillment of the Classification Criteria for Psoriatic Arthritis (CASPAR) criteria at Screening, with symptom...
- Has a diagnosis of active plaque psoriasis or documented history of plaque psoriasis.
- Has history of biologic disease-modifying antirheumatic drug (bDMARD)-naïve or bDMARD-inadequate response/intolerant.
You likely can't join if
- The main exclusion criteria include but are not limited to the following:
- Has any arthritis with onset before age 17 years or current diagnosis of inflammatory joint disease other than PsA (such as, but not limited to...
- Has a skin condition diagnosis, other than psoriasis that may, in the judgment of the investigator, interfere with the assessment of psoriasis.
- Has a history of cancer (except fully treated nonmelanoma skin cancers or cervical carcinoma in situ after complete surgical removal) and is disease...
- Has any active infection.
- Has known allergies, hypersensitivity, or intolerance to tulisokibart of its excipients.
The study team makes the final eligibility decision.
Where it's taking place
- Sun City, Arizona, United States
- Tucson, Arizona, United States
- Riverside, California, United States
- Thousand Oaks, California, United States
- Tujunga, California, United States
- Aventura, Florida, United States
- Tampa, Florida, United States
- Boise, Idaho, United States
- Rockville, Maryland, United States
- Kansas City, Missouri, United States
- Lincoln, Nebraska, United States
- Charlotte, North Carolina, United States
- Duncansville, Pennsylvania, United States
- Philadelphia, Pennsylvania, United States
- Summerville, South Carolina, United States
- Houston, Texas, United States
- Rimouski, Quebec, Canada
- Trois-Rivières, Quebec, Canada
- Santiago, Region M. de Santiago, Chile
- Barranquilla, Atlántico, Colombia
+ 19 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Sun City, Arizona, United States; Tucson, Arizona, United States; Riverside, California, United States; Thousand Oaks, California, United States; Tujunga, California, United States; Aventura, Florida, United States and 33 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.